Covenant Asset Management’s DexCom DXCM Stock Holding History

Covenant Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-30,097	Closed	-$3.87M	–	155
2023 Q2	$3.87M	Sell	30,097 -61	-0.2%	-$7.38K	0.98%	35
2023 Q1	$3.5M	Buy	30,158 +8,858	+42%	+$992K	0.83%	37
2022 Q4	$2.41M	Buy	21,300 +420	+2%	+$46.1K	0.58%	56
2022 Q3	$1.68M	Sell	20,880 -392	-2%	-$33.2K	0.48%	67
2022 Q2	$1.58M	Sell	21,272 -5,012	-19%	-$457K	0.5%	68
2022 Q1	$3.36M	Sell	26,284 -21,720	-45%	-$2.38M	0.91%	35
2021 Q4	$6.44M	Buy	48,004 +1,248	+3%	+$179K	1.71%	13
2021 Q3	$6.39M	Sell	46,756 -204	-0.4%	-$25.7K	1.9%	12
2021 Q2	$5.01M	Sell	46,960 -156	-0.3%	-$15K	1.49%	17
2021 Q1	$4.23M	Buy	47,116 +6,420	+16%	+$603K	1.32%	16
2020 Q4	$3.76M	Buy	40,696 +12,104	+42%	+$1.08M	1.24%	22
2020 Q3	$2.95M	Buy	28,592 +140	+0.5%	+$14.6K	0.94%	27
2020 Q2	$2.88M	Buy	+28,452	New	+$2.55M	0.64%	35

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Covenant Asset Management's DXCM Position: Q3 2023 in Review

Covenant Asset Management sold out of DexCom (DXCM) in Q3 2023, closing a stake of 30,097 shares — an estimated $3.87M sold.

Covenant Asset Management first reported a position in DXCM in Q2 2020 and held it in 13 quarters. The position peaked at $6.44M in Q4 2021. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

Covenant Asset Management reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
Covenant Asset Management sold 30,097 DexCom shares in Q3 2023, an estimated $3.87M.
Covenant Asset Management first reported a position in DexCom in Q2 2020 and held it in 13 quarters.
Covenant Asset Management's DexCom position peaked at $6.44M in Q4 2021.
903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Covenant Asset Management's 13F filing for Q3 2023, filed 31 Oct 2023.